Nektar Therapeutics (NASDAQ:NKTR)
| 0.7745 Delayed Data As of 3:59pm ET |  +0.0565 / +7.87%Today’s Change | 0.71 Today|||52-Week Range 6.26 | -65.73% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Zalevsky Jonathan Chief Research & Development Officer |  Sale | 8/18/2022 | 73,716 | $4.65 | $342.8K | -84.66% |
Robin Howard W President & Chief Executive Officer | Sale | 5/16/2022 | 36,529 | $3.95 | $144.3K | -81.49% |
Robin Howard W President & Chief Executive Officer | Sale | 11/16/2022 | 38,014 | $3.57 | $135.7K | -79.60% |
Zalevsky Jonathan Chief Research & Development Officer | Sale | 5/16/2022 | 21,673 | $3.95 | $85.6K | -81.49% |
Eastham Karin Director | Sale | 9/13/2022 | 21,267 | $3.61 | $76.8K | -79.77% |
Labrucherie Gilbert M Chief Operating & Financial Officer & Senior VP | Sale | 5/16/2022 | 17,448 | $3.95 | $68.9K | -81.49% |
Robin Howard W President & Chief Executive Officer | Sale | 8/16/2022 | 13,759 | $4.76 | $65.5K | -84.66% |
Robin Howard W President & Chief Executive Officer | Sale | 2/16/2023 | 19,635 | $3.00 | $58.9K | -75.91% |
Zalevsky Jonathan Chief Research & Development Officer | Sale | 8/16/2022 | 10,560 | $4.76 | $50.3K | -84.66% |
Zalevsky Jonathan Chief Research & Development Officer | Sale | 11/16/2022 | 13,460 | $3.57 | $48.1K | -79.60% |
Page of 4